EU OMBUDSMAN INCREASES PRESSURE ON EMA TO RELEASE DRUG ASSESSMENTS
June 1st, 2010
BY KEITH NUTHALL
THE EUROPEAN Ombudsman has made another demand that the European Medicines Agency (EMA) releases information about pharmaceuticals gathered during market approval assessments. P. Nikiforos Diamandouros has branded EMA guilty of maladministration when refusing Danish researchers access to clinical study reports and trial protocols for two anti-obesity drugs, not named in his ruling. The researchers wanted to conduct an independent analysis of their concerns about potential biased reporting on drug trials. EMA refused disclosure because it would ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.